Meena Arora

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA.

Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL.

Quadrant Pharmaceuticals LLC manufactures pharmaceutical products. The private company is based in New York, NY. The company was founded by Jack E. Stover.

Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.

Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly.

OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA.

Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ.

The Bone Marrow Foundation is a non profit organization which offers financial assistance and free support services to bone marrow or stem cell transplant patients and their families. The company was founded by Christina Merrill in 1992 and is headquartered in New York, NY.

The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY.

PDI, Inc. provides format printing services. It specializes in document management, electronic pre-media and on-site prepress management, to offset and full-color variable digital print, bindery, multimedia and internet services. The company was founded in February 2007 and is headquartered in Kirkland, Canada.

Liaoning Yisheng Biopharmaceutical Co., Ltd. operates as biopharmaceutical company. It focuses on the research, development, manufacturing and sales and marketing of immunological and vaccine products. The company is headquartered in Beijing, China.

Dechert LLP provides legal services. It serves the chemical, construction, finance and real estate, energy, insurance, and health sectors. The firm's practice areas include business restructuring and reorganization, commercial litigation, corporate and securities, energy, finance and real estate, financial services, mergers and acquisitions, and private equity. The company was founded in 1875 and is headquartered in Philadelphia, PA.

Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ.

Access Asset Managers Pvt Ltd. (Access Asset Managers) is a private equity firm founded by Nilesh Mehta and Sangeeta Modi in 2010. The firm is headquartered in Mumbai.

Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China.